Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

Jabil, Inc. JBL recently announced that it has completed the acquisition of Pharmaceutics International, Inc. for an ...

Jabil (JBL) reachead $163.62 at the closing of the latest trading day, reflecting a +1.11% change compared to its last close.

Learn more about whether Jabil Inc. or TD SYNNEX Corporation is a better investment based on AAII's A+ Investor grades, which ...